
|Articles|September 20, 2017
Industry Survey Reveals Clinical Data Management Delays are Slowing Study Completion
Advertisement
A survey recently completed by the industry revealed that the time it takes companies to design and release clinical study databases is having a negative impact on the completion of trials. The delays around the database lead to increased time for other data management processes which ultimately contributes to the slowing of study completion all together.
Read the full release
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
2
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
3
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
4
FDA Announces New Biosimilar-Targeted Draft Guidance
5





